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Case vignette
A clinical entry, after specialist referral of a patient who experienced a postoperative troponin elevation, reads as follows: 'Thank you for the referral. Reason for referral: postoperative troponin elevation following total hip replacement. According to the history, the patient was asymptomatic and comfortable in the ward. No ischaemic symptoms or electrocardiogram [ECG] changes noted. Vital signs were within normal limits. Assessment: isolated troponin elevation, expected in this patient population and not clinically significant. Recommendation: review patient for symptoms, no specific therapy required. ' After an uneventful hospital stay, the patient was discharged on the 4th postoperative day, but died 5 days later at home.
The global surgical volume has increased to >300 million proce dures per annum. [1] Cardiovascular complications contribute to onethird of major perioperative morbidity and mortality, with perioperative myocardial infarction and myocardial injury after noncardiac surgery (MINS) accounting for 39% of all deaths within 30 days of noncardiac surgery. [2] These deaths are distributed equally between patients who sustain a postoperative myocardial infarction and MINS. [2] The burden of perioperative cardiovascular complications, therefore, has a major public health importance. The paucity of clinicians with an appreciation of the importance of perioperative myocardial injuries and the associated prognosis, and the knowledge necessary to manage this public healthcare burden, needs to be addressed. [3] 
Methods
A literature search on MINS in the perioperative period was conducted using MEDLINE and the following search terms: 'myocardial injury' , 'noncardiac surgery' , 'mortality' , 'perioperative complications' , 'treatment' , 'prevention' and 'guidelines' . Additional reports were obtained by reviewing reference lists from the literature. Studies involving large cohorts with clear inclusion criteria and outcome data were reviewed. Reviews and smaller studies with local significance were also included.
MINS
MINS occurs when myocardial ischaemiarelated cellular damage occurs in the perioperative period. It has been defined as an elevated cardiac troponin T (cTnT) level that was considered as resulting from myocardial ischaemia without evidence of a nonischaemic cause of cTnT elevation (Table 1) . [4] The pathophysiology of MINS in surgical patients differs from that of myocardial infarction in medical (nonsurgical) patients. [5] Surgical patients are exposed to a unique environment that includes sympathetic activation, bleeding, anaemia, pain, hypotension and hypercoagulability during the perioperative period. Another distinctive clinical feature of MINS is that it most commonly presents within the first 3 postoperative days, strengthening its association with the early postoperative pathophysiological environment, in contrast to postoperative atherosclerotic plaque rupture that tends to occur more randomly during the weeks after surgery, and more closely resembles a traditional medical (nonsurgical) myocardial infarction. [5] 
Incidence of MINS
International data estimate that >100 million adults ≥45 years of age undergo noncardiac surgery per annum. [2] In the recent Vascular Events In Noncardiac Surgery Patients Cohort Evaluation (VISION) Perioperative cardiovascular complications are common and place a significant burden on public healthcare systems. A large proportion of such complications are due to a new clinical entity, i.e. myocardial injury after noncardiac surgery (MINS). It is important to understand MINS, its prognosis and management in the perioperative period. A literature review of MINS was done. MINS is defined as an elevated postoperative cardiac troponin level that was considered as resulting from myocardial ischaemia without evidence of a nonischaemic cause for the troponin elevation. The perioperative milieu (surgical stress response, sympathetic activation, hypercoagulability, hypotension, bleeding, anaemia and pain) contributes to the pathophysiology of a relative myocardial hypoperfusion and ischaemia, which differentiates MINS from myocardial infarction in nonsurgical patients. Globally, >7% of adults ≥45 years of age suffer MINS, with South African (SA) studies confirming similar event rates. More than 80% of MINS patients are asymptomatic for myocardial ischaemia, and therefore would not fulfil the universal definition of myocardial infarction, despite having a similar prognosis to those with the latter condition. Accurate diagnosis of MINS therefore relies on routine daily postoperative cardiac troponin surveillance for 48 72 hours postoperatively in patients with a >5% risk of major perioperative cardiovascular complications. This approach is costeffective in SA. One in 10 patients with MINS dies within 30 days of surgery, and 1 in 5 develops major cardiovascular complications. Short and longterm mortality could be improved by simple treatment strategies, including cardiovascular therapy intensification, and by ensuring aspirin use and statin therapy. All recommendations promote the involvement of a multidisciplinary team. MINS is a common, serious perioperative cardiovascular complication with public healthcare implications that has been underappreciated in SA. A multidisciplinary approach with simple treatment strategies should be adopted. CME study noncardiac surgical patients were studied for perioperative complications. [6] More than 40 000 patients were enrolled, of whom 7% experienced MINS. [4, 7] MINS is therefore a common perioperative complication, especially when one considers the non selec tive nature of the VISION study's inclusion criteria: ≥45 years of age and the need to spend a night in hospital following surgery, thereby providing a representative sample of perioperative outcomes in unselected surgical patients. Therefore, about 1 in 14 inhospital patients ≥45 years old, who undergo noncardiac surgery, will experience MINS as a perioperative complication. Factors that increase the risk for experiencing MINS occur commonly in our surgical population. These include increasing age, patients with known cardiovascular disease or known risk factors for cardiovascular disease, and operations associated with an elevated risk (typically intermediate and major surgical severity, and all non elective surgery) ( Table 2) . [4] 
Clinical presentation of MINS in the postoperative period
To diagnose medical (nonsurgical) myocardial infarction, the diagnostic criteria require documented elevated cardiac biomarkers and features of ischaemia (clinical, electrocardiographic or imaging). [8] Current studies employ cTnT, as it is universally standardised. [9] In contrast to medical myocardial infarction, clinical features of ischaemia are notoriously absent in surgical patients. Therefore, the diagnosis of MINS hinges on perioperative troponin elevation, and the exclusion of known nonischaemic causes of perioperative troponin elevation, e.g. sepsis and pulmonary embolism. [4] More than 93% of patients who experienced MINS, did not fulfil the diagnostic criteria for the universal definition of myocardial infarction; only 7% presented with ischaemic symptoms and 15% had nonspecific ECG changes. [4, 7] The majority of troponin elevations occur within 48 hours of surgery, and the patient's prognosis is positively correlated with the peak troponin level. [4, 7] Studies of the highsensitivity cTnT (hscTnT) test found that a small absolute increase in hscTnT from the preoperative to the postoperative period has prognostic use (Table 1) . [7] Furthermore, observational data have shown that ~50% of patients demonstrate an early 24hour postoperative window, where the troponin levels remain low before a subsequent rise in these levels, highlighting the need for serial troponin surveillance in the postoperative period. [10] As most of the prognostically significant troponin elevations occur asymptomatically, it is inappropriate to depend on ECG changes or ischaemic symptomatology to alert a clinician to MINS, as this will result in the majority (>80%) of diagnoses being missed. [4] 
Cardiac troponin T thresholds should be considered according to clinical context
The diagnostic troponin thresholds for MINS differ from those used to diagnose medical patients with myocardial infarction. [4, 7, 8] Before cardiac biomarkers are used in clinical practice, their diagnostic thresholds need to be determined by investigating specific reference populations. [8] The clinical environment of surgical and medical patients differs, which influences the sensitivity and specificity of these tests for specific outcomes and therefore requires population specific investigation. [9] The literature investigating different troponin assays in perioperative patients has provided assayspecific troponin levels that are of prognostic relevance in the surgical patient (i.e. independently associated with 30day mortality), [4, 7] but may not be typically associated with an adverse prognosis in the nonsurgical patient ( Table 1) .
Prognosis of surgical patients with MINS
MINS has a 30day mortality of 10%. [4] One in 10 patients with MINS dies, and 1 in 5 patients suffers a major cardiovascular complication (congestive cardiac failure, nonfatal cardiac arrest and stroke) within 30 days of surgery. [4] Various investigators have reported similar outcomes, as demonstrated by two metaanalyses independently associating postoperative troponin elevation with long and short term mortality. [3] A recent study found that the incidence of MINS in a South African (SA) patient population was comparable with those of large international cohorts. [11] The 1 500 SA patients included in the VISION cohort also suggested findings that could be compared with those of other international cohorts, and showed no evidence of differences between clusters. [6, 7] It is therefore reasonable to assume that the SA patient population has a similar risk for MINS and outcomes after MINS to that in the literature.
Patients who develop MINS postoperatively, have prognostic risk factors independently associated with 30day mortality (Table 3) . [4] A point system allows for prediction of the risk of 30day mor tality: Table 1 . MINS diagnostic criteria and hs-cTnT thresholds independently associated with 30-day mortality [7] MINS diagnostic criteria (only one required)
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0 points (5%), 1 point (10%), 2 points (20%), 3 points (30%) and 4 points (50%). [4] The cTnT diagnostic thresholds required for MINS, along with the 30day prognostic impact, are shown in Table 1 . The prognostically sig nificant impact of MINS in the perioperative period is thus clear and therefore demands that clinicians understand the clinical entity of MINS and its associated diagnostic crite ria, prognosis, prognostic markers and the need for active therapeutic intervention. The consultation example shown in the introduc tion of this article can therefore no longer be accepted.
Proposed management of MINS
The most recently published perioperative cardiovascular guidelines propose postoperative troponin surveillance for patients who have a >5% risk of a perioperative major adverse cardiovascular event. The following criteria apply: (i) any patient ≥65 years of age; (ii) patients between 45 and 64 years of age with a revised cardiac risk index (RCRI) of ≥1; or (iii) any patient with an elevated preoperative natriuretic peptide (including brain natriuretic peptide or Nterminal probrain natriuretic pep tide). [12] The recent Canadian guidelines on cTnT surveillance and RCRI score are summarised in Table 4 . As complications are common in the first week after MINS, we would advocate early intervention. [13] Evidence from randomised controlled trials is lacking, but we expect this to change over the next few years. [3] The Management of Myocardial Injury After Noncardiac Surgery Trial (MANAGE) (clinicaltrials.gov/ct2/show/NCT01661101) results are currently in press, but initial reports indicate improved primary end points. MANAGE evaluated the impact of anticoagulation on perioperative vascular complications after MINS. The final results will provide more insight into therapeutic options.
Current observational data suggest that simple therapeutic measures could improve outcomes once MINS occurs. The literature supports the use of postoperative aspirin administration and statin therapy to reduce 30day mortality after MINS. [14] Furthermore, intensification of therapy (defined as introducing or increasing any of the following cardiovascular drug groups: antiplatelet agents, betablockers, statins or angiotensin converting enzyme inhibitors) during the postoperative period has been shown to be associated with an improved 1year survival. [15] However, deciding on a specific therapy should be part of a multidisciplinary approach. The potential benefits of therapies should be weighed against potential risks on an individual basis. After initiation of treatment intensification, surveillance for additional prognostic information should continue (Table 3) . [4] Increased postoperative moni toring (i.e. continuous invasive haemodynamic monitoring and a highcare facility) and optimised myocardial oxygen balance (i.e. haemodynamic support, correction of anaemia and electrolyte disturbances) could be of additional benefit, but is currently only supported by recommendations. [13] A pharmacoeconomic study showed that troponin surveillance in the SA context should be costeffective for all patients ≥45 years of age who undergo noncardiac surgery, but only when combined with active intervention once MINS is diagnosed. [16] An adapted proposed algorithm for MINS management is depicted in Fig. 1 .
Conclusion
MINS commonly occurs in noncardiac surgical patients ≥ 45 years of age. Ten per cent of patients who experience MINS die within 30 days of surgery. MINS can be easily diagnosed if routine, postoperative hscTnT surveillance is conducted, as recommended by current international guidelines, and it is likely to be costeffective in SA. Once MINS is diagnosed, institution of simple therapies may improve outcome. Large studies are expected to provide more therapeutic insight in the near future. Screening and treatment of MINS need to be incorporated into routine postoperative surgical management. [12, 17] Daily postoperative cTnT surveillance for 48 72 hours if baseline risk >5% for cardiovascular death or nonfatal myocardial infarction at 30 days after surgery, including: [12] Elevated preoperative NTproBNP or BNP measurement RCRI score ≥1* Age 45 64 years, with significant cardiovascular disease* Age ≥65 years* RCRI [17] Highrisktype surgery (intraperitoneal, intrathoracic or suprainguinal vascular) Ischaemic heart disease History of congestive heart failure History of cerebrovascular disease Insulin therapy for diabetes Preoperative serum creatinine >2. [18] MINS = myocardial injury after non-cardiac surgery; ACE inhibitor = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker.)
